KELSEY MOON: Open Payments
NPI 1962852186 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124 in 7 payments from 5 companies in 2025. Trend: 2023 $1,295 · 2024 $866 · 2025 $124
Food & beverage: $124
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $27 |
| Medtronic, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: QULIPTA, INCEPTIV, UBRELVY, FREESTYLE LIBRE 3, ELIQUIS, TRELEGY ELLIPTA, SHINGRIX.
Industry payments across MO — which companies pay providers there.
